PMAM
GBT

Picton Mahoney Asset Management’s Global Blood Therapeutics, Inc. GBT Stock Holding History

Picton Mahoney Asset Management’s Portfolio GBT Stock Details GBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-221,191
Closed -$15.1M – 866
2022
Q3 		$15.1M Buy
+221,191
New +$12.2M 0.54% 27

Other funds holding GBT

BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Picton Mahoney Asset Management's GBT Position: Q4 2022 in Review

Picton Mahoney Asset Management sold out of Global Blood Therapeutics, Inc. (GBT) in Q4 2022, closing a stake of 221,191 shares — an estimated $15.1M sold.

Picton Mahoney Asset Management first reported a position in GBT in Q3 2022 and held it in 1 quarter. The position peaked at $15.1M in Q3 2022. 2 funds tracked by Wall St. Rank hold GBT as of Q4 2022.

  • Picton Mahoney Asset Management reported no remaining Global Blood Therapeutics, Inc. position as of Q4 2022 after selling out during the quarter.
  • Picton Mahoney Asset Management sold 221,191 Global Blood Therapeutics, Inc. shares in Q4 2022, an estimated $15.1M.
  • Picton Mahoney Asset Management first reported a position in Global Blood Therapeutics, Inc. in Q3 2022 and held it in 1 quarter.
  • Picton Mahoney Asset Management's Global Blood Therapeutics, Inc. position peaked at $15.1M in Q3 2022.
  • 2 funds tracked by Wall St. Rank held Global Blood Therapeutics, Inc. as of Q4 2022.

Based on Picton Mahoney Asset Management's 13F filing for Q4 2022, filed 13 Feb 2023.